Cells harboring infectious, but transcriptionally latent, human immunodeficiency virus type 1 (HIV-1) proviruses currently pose an insurmountable barrier to viral eradication in infected patients. To better understand the molecular basis for HIV-1 latency, we used the J-Lat model of postintegration HIV-1 latency to assess the kinetic relationship between the induction of NF-B and the activation of latent HIV-1 gene expression. Chromatin immunoprecipitation analyses revealed an oscillating pattern of RelA recruitment to the HIV-1 long terminal repeat (LTR) during continuous tumor necrosis factor alpha (TNF-) stimulation. RNA polymerase II (Pol II) recruitment to the HIV-1 LTR closely mirrored RelA binding. Transient stimu-lation of cells wit...
The transcription factor NF-kappaB plays a central role in the human immunodeficiency virus type 1 (...
Transcriptional silencing of HIV in CD4 T cells generates a reservoir of latently infected cells tha...
Despite its clinical importance, the molecular biology of HIV-1 latency control is at best partially...
Human immunodeficiency virus type 1 (HIV-1) is able to establish a persistent latent infection durin...
Latent HIV-1 proviruses are capable of reactivating productive lytic infection, but the precise mole...
Background: Retroviruses rely on host factors for cell entry, replication, transcription, and other ...
Background: Molecular latency allows HIV-1 to persist in resting memory CD4+ T-cell...
A major barrier to development of a cure for HIV-1 is the ability of the virus to establish latent i...
Latently infected cells rapidly initiate HIV transcription after exposure to signals that induce NF-...
SummaryEradication of the latent HIV reservoir remains a major barrier to curing AIDS. However, the ...
The balance between latent and productive human immunodeficiency virus (HIV) infection is the result...
The use of antiretroviral therapy in HIV type 1 (HIV-1)–infected patients does not lead to virus era...
The establishment of a stable reservoir of latently infected cells allows HIV to persist in the host...
AbstractReservoir cells latently infected with HIV-1 pose one of the major obstacles that hamper ult...
Transcription ofhuman immunodeficiency virus type 1 (HIV-1) depends on the function of the virus-enc...
The transcription factor NF-kappaB plays a central role in the human immunodeficiency virus type 1 (...
Transcriptional silencing of HIV in CD4 T cells generates a reservoir of latently infected cells tha...
Despite its clinical importance, the molecular biology of HIV-1 latency control is at best partially...
Human immunodeficiency virus type 1 (HIV-1) is able to establish a persistent latent infection durin...
Latent HIV-1 proviruses are capable of reactivating productive lytic infection, but the precise mole...
Background: Retroviruses rely on host factors for cell entry, replication, transcription, and other ...
Background: Molecular latency allows HIV-1 to persist in resting memory CD4+ T-cell...
A major barrier to development of a cure for HIV-1 is the ability of the virus to establish latent i...
Latently infected cells rapidly initiate HIV transcription after exposure to signals that induce NF-...
SummaryEradication of the latent HIV reservoir remains a major barrier to curing AIDS. However, the ...
The balance between latent and productive human immunodeficiency virus (HIV) infection is the result...
The use of antiretroviral therapy in HIV type 1 (HIV-1)–infected patients does not lead to virus era...
The establishment of a stable reservoir of latently infected cells allows HIV to persist in the host...
AbstractReservoir cells latently infected with HIV-1 pose one of the major obstacles that hamper ult...
Transcription ofhuman immunodeficiency virus type 1 (HIV-1) depends on the function of the virus-enc...
The transcription factor NF-kappaB plays a central role in the human immunodeficiency virus type 1 (...
Transcriptional silencing of HIV in CD4 T cells generates a reservoir of latently infected cells tha...
Despite its clinical importance, the molecular biology of HIV-1 latency control is at best partially...